Clean Science & Technology Ltd was incorporated in 2003 and is one of the leading global manufacturers of functionally critical specialty chemicals. Its portfolio includes performance chemicals such as MEHQ, BHA, and AP, pharmaceutical intermediates including Guaiacol and DCC, and FMCG chemicals like 4-MAP and Anisole.
Q1 FY26 Earnings Results:
Revenue: ₹220 crore, up 1.38% year-on-year YoY from ₹217 crore
Total Expenses: ₹130 crore, down 0.76% YoY from ₹131 crore
Consolidated Net Profit PAT: ₹77 crore, up 6.94% YoY from ₹72 crore
Earnings Per Share EPS: ₹7.21, up 6.19% YoY from ₹6.79
Operational & Strategic Update:
Revenue Growth: Revenue saw a modest increase of 1.38%, supported by stable demand across the performance chemicals and pharmaceutical intermediates segments
Cost Management: Total expenses declined marginally, reflecting efficient cost control and operational discipline
Profitability: Net profit rose nearly 7% YoY, driven by better margins and controlled costs despite moderate topline growth
Product Portfolio: Continued leadership in key product categories helped the company retain its global customer base and strengthen market positioning
Strategic Initiatives: Investments in process innovation, automation, and capacity expansion continued to drive operational efficiency and future growth
Corporate Developments in Q1 FY26:
Clean Science & Technology reported steady topline performance and healthy profit growth in Q1 FY26. Consistent cost optimization, product innovation, and strategic focus on specialty chemicals supported its robust results.
Looking Ahead:
The company plans to further expand product capacities, enhance global reach, and invest in new specialty chemical launches to fuel growth in FY26 and beyond.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.